Real-time enrollment status for this basal ganglia intracerebral hemorrhage clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 8:09 PM UTC
| NCT Number | NCT07260916 |
| Recruiting Status | Recruiting |
| Condition | Basal Ganglia Intracerebral Hemorrhage |
| Phase | NA |
| Target Enrollment | 300 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | September 15, 2026 (4 weeks ago) |
As of October 14, 2026: Clinical trial NCT07260916 is currently recruiting participants. This na study for basal ganglia intracerebral hemorrhage is actively seeking new participants at 44 locations across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07260916 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07260916 was last updated 4 weeks ago (September 15, 2026). HelloStudys verifies this status automatically.